Main CVM's regular meeting with key regulatory counterparts in Canada and the European Union and with other significant regulatory partners assure the close and timely communication necessary to deal effectively with emerging problems. Each meeting is set up with a specific agenda designed to share subjects and issues of mutual interest and concern. Strengthening public health and animal health regulatory infrastructures between our most significant trading partners helps to assure the quality, safety, and efficacy of products from those countries. <i>Information is current as of February 28, 2013.</i> Percent column

FY 2011 Overall: 100

Oct - Dec 2010 95 100 Jan - Mar 2011 95 100 Apr - Jun 2011 95 100 Jul - Sept 2011 95 100

FY 2012 Overall: 100

Oct - Dec 2011 95 100 Jan - Mar 2012 95 100 Apr - Jun 2012 95 100 Jul - Sept 2012 95 100

FY 2013 YTD: 100

Oct - Dec 2012 95 100 Jan - Mar 2013 95 Apr - Jun 2013 95 Jul - Sept 2013 95 Sub Percentage of bilateral meetings conducted in the quarter Number column Target

FY 2011 Total: 25

Oct - Dec 2010 N/A 1 Jan - Mar 2011 N/A 8 Apr - Jun 2011 N/A 11 Jul - Sept 2011 N/A 5 Target

FY 2012 Total: 43

Oct - Dec 2011 N/A 11 Jan - Mar 2012 N/A 15 Apr - Jun 2012 N/A 14 Jul - Sept 2012 N/A 7 Target

FY 2013 YTD: 11

Oct - Dec 2011 N/A 11 Jan - Mar 2012 N/A Apr - Jun 2012 N/A Jul - Sept 2012 N/A Sub Percentage of bilateral meetings conducted in the quarter Number column Target

FY 2011 Total: 25

Oct - Dec 2010 N/A 1 Jan - Mar 2011 N/A 8 Apr - Jun 2011 N/A 11 Jul - Sept 2011 N/A 5 Target

FY 2012 Total: 43

Oct - Dec 2011 N/A 11 Jan - Mar 2012 N/A 15 Apr - Jun 2012 N/A 14 Jul - Sept 2012 N/A 7 Target

FY 2013 YTD: 11

Oct - Dec 2011 N/A 11 Jan - Mar 2012 N/A Apr - Jun 2012 N/A Jul - Sept 2012 N/A http://www.fda.gov/AboutFDA/Transparency/track/ucm203425.htm FDA-TRACK CVM Dashboard ਍††਍਍਍਍਍਍਍